Health Systems in Industrialized Countries

Author(s):  
Bianca K. Frogner ◽  
Peter S. Hussey ◽  
Gerard F. Anderson

This article focuses on the health systems of industrialized countries which are members of the Organization for Economic Co-operation and Development (OECD). It begins with an overview of the various ways to finance health systems in industrialized countries. It discusses the factors generally considered to be the major factors contributing to rising health care spending and the variation in the levels of health care spending across the OECD countries. However, many of the fundamental drivers of health spending growth are shared across countries: most notably, technological diffusion and the shift of the disease burden toward chronic diseases. This article determines successful approaches to manage these drivers of spending while improving the quality and outcomes achieved should be a priority for OECD countries.

2007 ◽  
Vol 227 (5-6) ◽  
Author(s):  
Hans Adam

SummaryIn 2005, total health spending in Germany amounted to € 239,4 billion or € 2900 per capita. Given the aging of the population in the next decades and the progress in medical technology there are some doubts about the affordability of health spending growth. One important criterion which has been proposed is that increasing health care spending should not lead to an absolute reduction of real per capita non-health care consumption. Calculations for the period 2005-2075 show that non-health consumption will not fall if per capita health care spending growth exceeds per capita gross domestic product growth by 1 percentage point. Health care spending as a share of the gross domestic product will rise from 10.4 percent in 2005 to 21 percent in 2075. An increase in the ratio of health care spending to the gross domestic product must be expected to change the funding of the German health care system. The public provision of health care will decline while the share of income devoted to private health spending (additional insurance, out-of-pocket-payments) will increase.


2016 ◽  
Vol 53 (1) ◽  
pp. 138-155 ◽  
Author(s):  
Laura A. Hatfield ◽  
Melissa M. Favreault ◽  
Thomas G. McGuire ◽  
Michael E. Chernew

2009 ◽  
Vol 70 (8) ◽  
pp. 460-464
Author(s):  
Shikha Sharma

According to the Centers for Medicare and Medicaid Services (CMS), the United States is projected to spend more than $2.5 trillion on health care in 2009, or $8,160 per U.S. resident. Health spending in 2009 is projected to account for 17.6 percent of gross domestic product.1 Despite high spending, nearly 46 million Americans are still uninsured. While policy and law makers agree that health care reform is needed, they disagree on how to contain the escalating health care costs and offer universal coverage. Some have suggested imposing price controls and strict budgets on health care spending, and others support free . . .


2009 ◽  
Vol 23 (4) ◽  
pp. 392-395 ◽  
Author(s):  
Neil Bhattacharyya

Background The objective of this study was to determine the disease burden of sinusitis relative to other medical conditions. Methods The adult sample of the National Health Interview Survey for calendar years 1997 to 2006 was analyzed, extracting 1-year prevalence data for the disease conditions sinusitis, hay fever, peptic ulcer, acute asthma, and chronic bronchitis. Disease burden data for emergency room visits, general and specialist visits, health care spending, and workdays lost were also extracted. The influence of each disease condition on disease burden variables was statistically determined. Comparisons among outcomes variables were conducted across disease conditions to determine their relative economic and health care impacts. Results Adult patients were studied (313,982; mean age, 45.2 years). The 1-year disease prevalences were: sinusitis (15.2%), hay fever (8.9%), ulcer (2.4%), acute asthma (3.8%), and chronic bronchitis (4.8%). Patients with sinusitis were significantly more likely to: visit the emergency room (22.7% versus 17.4%, p < 0.001), spend greater than $500/year on health care (55.8% versus 45.0%, p < 0.001), and see a medical specialist (33.6% versus 22.3%, p < 0.001), than those without sinusitis. Patients with sinusitis missed an average of 5.67 workdays per 12 months versus 3.74 workdays for those without (p < 0.001). The number of workdays lost with sinusitis was similar to that of acute asthma (5.79 workdays, p > 0.05), and health care spending with sinusitis was significantly greater than that of ulcer disease, acute asthma, and hay fever (p < 0.004). Conclusions Sinusitis imparts a significant disease burden both within and outside of the health care system that is comparable with or exceeds that of other conditions commonly thought to be more serious.


1994 ◽  
Vol 8 (3) ◽  
pp. 67-73 ◽  
Author(s):  
James M Poterba

This brief paper explores the likely effects of government-imposed global budget caps, such as those in the Clinton administration proposal, on health care spending. It argues that health reform proposals that guarantee universal access to a basic package of medical benefits create a substantial new constituency for higher health care outlays. Political and potential legal pressures to expand rather than limit the set of guaranteed benefits, coupled with an expansion of the number of individuals with health insurance coverage, make it unlikely that global budget targets will succeed in reducing the rate of health care spending growth.


Sign in / Sign up

Export Citation Format

Share Document